Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Neuropathol Exp Neurol. 2013 Sep;72(9):824–832. doi: 10.1097/NEN.0b013e3182a0a39f

Figure 4.

Figure 4

CSF Tau cleaved by caspase 6 (TauΔCasp6) levels of Parkinson disease (PD) and multiple sclerosis (MS) patients are significantly lower than those of Alzheimer disease (AD) patients. Levels of CSF TauΔCasp6 in AD (n = 5) vs. MS (n = 5) and PD (n = 5) cases. ***p < 0.001 vs. AD (one-way ANOVA followed by a Tukey-Kramer post hoc analysis).